NEW YORK (GenomeWeb News) – Health Discovery Corporation has partnered with DCL Medical Laboratories to develop and commercialize DCL’s diagnostic tests for ovarian, cervical, and endometrial cancers.

 

Under the agreement, Savannah, Ga.-based HDC will own the developed intellectual property and DCL will have a sole-use license for applications and new mathematical tools that are developed over the course of the collaboration.